+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

GlaxoSmithKline plc - Enterprise Tech Ecosystem Series

1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


Action Potential Venture Capital is the bioelectronic medicines venture arm of GSK. It is focused on investing in start-ups which are involved in development of neuromodulation medical devices and adaptive bioelectronics. Headquartered in Palo Alto, the venture arm invests in start-ups across the globe.

The report provides information and insights into GSK's tech activities, including -
  • Insights of its digital transformation strategies and venture arm
  • Overview of technology initiatives covering partnerships and technology launches
  • Insights on each technology initiative including technology theme, objective, and benefits
  • Details of estimated ICT budgets and major ICT contracts.

  • GlaxoSmithKline is tapping key disruptive technologies to strengthen its operational and service competences. Artificial Intelligence, IoT, Big Data, Blockchain, Mobile Health, Robotics, and Augmented Reality are the key technologies under focus for the company. Cloud, Genomic, and Ecommerce are the other focusing areas of the company.
  • GlaxoSmithKline plc is investing in emerging technologies and is also building an internal team with data, analytics and insights, content, media, and e-commerce experts to win the digital competition.
  • Using AI and machine learning (ML) for Drug Discovery & Development
  • Focus on Functional Genomics

Reasons to Buy
  • Gain insights into GSK's tech operations.
  • Gain insights into its tech strategies and innovation initiatives.
  • Gain insights into its technology themes under focus.
  • Gain insights into various product launches and partnerships strategies of GSK

Table of Contents

  • Digital Transformation Strategy
  • Disruptive Tech Theme Map
  • Technology Initiatives
  • Key Executives
  • Venture Arm-SR One
  • SR One Investments
  • Action Potential Venture Capital (APVC) Venture Arm
  • ICT Budget & Contracts
  • Investor - Partner Network Map
  • Disclaimer

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Cloud Pharmaceuticals
  • Insilico Medicine
  • Exscientia
  • Cisco
  • The Weather Company
  • JD.com
  • Propeller Health
  • Verily Life Sciences